4

The Spinal Muscular Atrophy volume gives some historical information on the disease and its treatment in the opening sections. Their timeline and attribution of credit is rather different from that of KEI, especially where Kaspar is concerned. Gene therapy for SMA was made possible by identifying the responsible gene in 1990 by Gilliam’s group in New York ...


Only top voted, non community-wiki answers of a minimum length are eligible